Emerson FY2026: Q4 sales up 7.0%, adjusted EPS just below consensus
Emerson closed FY2026 with Q4 sales of $5.201 billion, up 7.0%, and FY sales of $18.982 billion, up 5.0%. Adjusted EPS was $1.86 in Q4 versus the $1.8724 consensus, a narrow miss, while FY adjusted EPS reached $6.59. Read the scorecard around that mix: demand and cash flow look healthy, but the structured cost lines in the input are not on the same period as revenue, so margin signals need caution.
1 · Expected vs. Actual
Free preview belowQ4 GAAP EPS was $1.33, up 24.0%, and adjusted EPS was $1.86, up 15.0%; the adjusted figure was $0.0124 below the $1.8724 consensus. Full-year GAAP EPS was $4.79 and adjusted EPS was $6.59. The GAAP-to-adjusted gap is mostly amortization of intangibles ($1.38 per share for FY2026) and restructuring ($0.36), so investors should focus on whether those costs are truly non-recurring.
Q4 net sales were $5.201 billion, up 7.0% from $4.855 billion, and full-year sales were $18.982 billion, up 5.0% from $18.016 billion. Underlying sales rose 7.0% in Q4 and 4.0% for the year, so currency and deal effects were not the main driver. Q4 segment growth was broad: Control Systems & Software and Test & Measurement each rose 14.0%, while Sensors rose 4.0%, Final Control 5.0% and Safety & Productivity 2.0%.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-10
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.